Form 8-K - Current report:
SEC Accession No. 0001404644-25-000014
Filing Date
2025-03-24
Accepted
2025-03-24 16:14:11
Documents
68
Period of Report
2025-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20250324.htm   iXBRL 8-K 27954
2 EX-99.1 ngne_4qyerelease.htm EX-99.1 23238
3 EX-99.2 a202503_ngnecorporatepre.htm EX-99.2 59849
7 a202503_ngnecorporatepre001.jpg GRAPHIC 103910
8 a202503_ngnecorporatepre002.jpg GRAPHIC 275996
9 a202503_ngnecorporatepre003.jpg GRAPHIC 98800
10 a202503_ngnecorporatepre004.jpg GRAPHIC 59498
11 a202503_ngnecorporatepre005.jpg GRAPHIC 130424
12 a202503_ngnecorporatepre006.jpg GRAPHIC 37699
13 a202503_ngnecorporatepre007.jpg GRAPHIC 120020
14 a202503_ngnecorporatepre008.jpg GRAPHIC 116226
15 a202503_ngnecorporatepre009.jpg GRAPHIC 86521
16 a202503_ngnecorporatepre010.jpg GRAPHIC 83362
17 a202503_ngnecorporatepre011.jpg GRAPHIC 83434
18 a202503_ngnecorporatepre012.jpg GRAPHIC 78053
19 a202503_ngnecorporatepre013.jpg GRAPHIC 102024
20 a202503_ngnecorporatepre014.jpg GRAPHIC 128999
21 a202503_ngnecorporatepre015.jpg GRAPHIC 103377
22 a202503_ngnecorporatepre016.jpg GRAPHIC 101325
23 a202503_ngnecorporatepre017.jpg GRAPHIC 101537
24 a202503_ngnecorporatepre018.jpg GRAPHIC 92489
25 a202503_ngnecorporatepre019.jpg GRAPHIC 115574
26 a202503_ngnecorporatepre020.jpg GRAPHIC 81029
27 a202503_ngnecorporatepre021.jpg GRAPHIC 134160
28 a202503_ngnecorporatepre022.jpg GRAPHIC 30071
29 a202503_ngnecorporatepre023.jpg GRAPHIC 92072
30 a202503_ngnecorporatepre024.jpg GRAPHIC 145703
31 a202503_ngnecorporatepre025.jpg GRAPHIC 129495
32 a202503_ngnecorporatepre026.jpg GRAPHIC 118609
33 a202503_ngnecorporatepre027.jpg GRAPHIC 122967
34 a202503_ngnecorporatepre028.jpg GRAPHIC 112414
35 a202503_ngnecorporatepre029.jpg GRAPHIC 100900
36 a202503_ngnecorporatepre030.jpg GRAPHIC 75708
37 a202503_ngnecorporatepre031.jpg GRAPHIC 100833
38 a202503_ngnecorporatepre032.jpg GRAPHIC 75229
39 a202503_ngnecorporatepre033.jpg GRAPHIC 119907
40 a202503_ngnecorporatepre034.jpg GRAPHIC 37158
41 a202503_ngnecorporatepre035.jpg GRAPHIC 61623
42 a202503_ngnecorporatepre036.jpg GRAPHIC 30229
43 a202503_ngnecorporatepre037.jpg GRAPHIC 103553
44 a202503_ngnecorporatepre038.jpg GRAPHIC 152273
45 a202503_ngnecorporatepre039.jpg GRAPHIC 114093
46 a202503_ngnecorporatepre040.jpg GRAPHIC 131054
47 a202503_ngnecorporatepre041.jpg GRAPHIC 126729
48 a202503_ngnecorporatepre042.jpg GRAPHIC 100010
49 a202503_ngnecorporatepre043.jpg GRAPHIC 105102
50 a202503_ngnecorporatepre044.jpg GRAPHIC 143302
51 a202503_ngnecorporatepre045.jpg GRAPHIC 134791
52 a202503_ngnecorporatepre046.jpg GRAPHIC 120509
53 a202503_ngnecorporatepre047.jpg GRAPHIC 90285
54 a202503_ngnecorporatepre048.jpg GRAPHIC 90589
55 a202503_ngnecorporatepre049.jpg GRAPHIC 82830
56 image_0a.jpg GRAPHIC 3474
57 image_1a.jpg GRAPHIC 34535
58 image_2a.jpg GRAPHIC 54682
59 image_3a.jpg GRAPHIC 40393
  Complete submission text file 0001404644-25-000014.txt   7454429

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20250324.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20250324_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20250324_pre.xml EX-101.PRE 13050
70 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20250324_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 25764327
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)